Carbon monoxide is an important gasotransmitter in mammals, with pleiotropic therapeutic
potential against a wide range of human diseases. However, clinical translation of CO is …

As one of the three known gasotransmitters, carbon monoxide (CO) has demonstrated
therapeutic potential against a wide range of human diseases. However, development of CO …

Conspectus Carbon monoxide is widely acknowledged as an important gasotransmitter in
the mammalian system with importance on par with that of nitric oxide. It has also been firmly …

Carbon monoxide (CO) is a known endogenous signaling molecule with potential
therapeutic indications in treating inflammation, cancer, neuroprotection, and sickle cell …

Carbon monoxide prodrugs with triggered release profiles are highly desirable for targeted
CO delivery to minimize their untoward side-effects. Herein, we describe a series of pH …

Carbon monoxide (CO) is widely known for its strong binding affinity to heme proteins and
for its potential toxicity. This chapter examines the current landscape of targeted CO delivery …

Carbon monoxide belongs to the family of signaling molecules and has been shown to
possess therapeutic effects. Similar to NO, safe delivery of CO is a key issue in developing …

Carbon monoxide (CO) is an endogenously produced gasotransmitter in mammals, and
may have signaling roles in bacteria as well. It has many recognized therapeutic effects. A …

The use of Carbon Monoxide (CO) as a therapeutic agent has already been tested in human
clinical trials. Pre-clinically, CO gas administration proved beneficial in animal models of …

Carbon monoxide-releasing molecules (CORMs) are promising candidates for producing
carbon monoxide in the mammalian body for therapeutic purposes. At higher …